<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: matrix metalloproteinases</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Antibiotic studied to reduce hemorrhagic stroke damage</title>
   	 <description>A new study will help determine if an antibiotic is a partial antidote for the poisonous effect blood has on the brain following a hemorrhagic stroke, researchers say.</description>
     <link>http://medicalxpress.com/news/2013-04-antibiotic-hemorrhagic.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 01 Apr 2013 11:20:28 EST</pubDate>
	 <guid isPermaLink="false">news284034018</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/antibioticst.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find new clue to clinical trial failures of MMP cancer therapies</title>
   	 <description>Proposed cancer therapeutic drugs based on blocking the catalytic activities of matrix metalloproteinases (MMPs), which profoundly remodel the environment surrounding a breast cell, have performed poorly in clinical trials. In mouse studies of MMP14, an enzyme that is often highly expressed in breast cancer, Berkeley Lab researchers have found a possible clue as to why. If confirmed for other MMPs, the finding could point the way to new strategies for future MMP-based cancer therapies.</description>
     <link>http://medicalxpress.com/news/2013-02-clue-clinical-trial-failures-mmp.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 12 Feb 2013 08:09:36 EST</pubDate>
	 <guid isPermaLink="false">news279878956</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/berkeleylabr.jpg" width="90" height="90" />
</item>
<item>
     <title>Correlates of diabetic foot complications identified</title>
   	 <description>(HealthDay) -- For patients with diabetes, increased poly(ADP-ribose) (PAR) immunoreactivity, reduced abundance of type 1 procollagen, and impaired skin structure correlate with foot complications, according to a study published online June 29 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-07-diabetic-foot-complications.html</link>
	 <category>Diabetes</category>
	 <pubDate>Sun, 08 Jul 2012 05:51:10 EST</pubDate>
	 <guid isPermaLink="false">news260945452</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/correlatesof.jpg" width="90" height="90" />
</item>
<item>
     <title>Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment</title>
   	 <description>It should be possible to significantly improve the response of common cancers to existing &quot;classical&quot; chemotherapy drugs, say scientists at Cold Spring Harbor Laboratory (CSHL), by introducing agents that alter the interaction of cancer cells with their immediate surroundings, called the tumor microenvironment.</description>
     <link>http://medicalxpress.com/news/2012-04-imaging-response-cancer-drugs-boosted.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 Apr 2012 12:59:03 EST</pubDate>
	 <guid isPermaLink="false">news253799935</guid>
	 
</item>


</channel>
</rss>
